ABSTRACT Few studies have evaluated the epidemiology and risk factors of hepatitis C virus (HCV) infection in children in Egypt. This study of 465 children attending Assiut University Hospital measured the rates of anti-HCV positivity by 3rd-generation ELISA test and of HCV-RNA positivity by PCR, with analysis of some relevant risk factors. The rate of HCV-RNA positivity among ELISA-positive cases (n = 121) was 72.2% overall: 100% in the subgroup with hepatitis, 70.8% in those with a history of multiple transfusions and 58.3% in those without hepatitis or multiple transfusions. History of blood transfusions, frequent injections, hospitalization or surgical procedures were significant risk factors for anti-HCV positivity by ELISA.
Introduction
Infection with hepatitis C virus (HCV) is a major global health care problem. The World Health Organization (WHO) estimates that up to 3% of the world's population has been infected with the virus [1] . The infection rate ranges from as low as 0.1% in Canada to the extremely high rate of 18.1% in Egypt [2] . Indeed, HCV infection is now the leading reason for liver transplantation worldwide.
Few studies have evaluated the epidemiology and risk factors of HCV infection in children in Egypt. In community-based studies the prevalence of HCV antibodies in Egyptian children was 3% and 9% in the Upper and Lower Egypt areas respectively [3] . Most studies have reported the rate of anti-HCV positivity by enzyme-linked imunosorbent assay (ELISA) rather than by the use of polymerase chain reaction (PCR) methods for detection of positivity. While ELISA is an economic way to screen a large number of patients and to rule out HCV infection, HCV-RNA provides a direct measure of viral load. Considering the silent evolution of HCV infection in children, periodic screening for the infection has become mandatory to prevent liver complications and to predict which patients will develop a more aggressive form of the disease [4] .
The aim of the present study was to assess the rate of HCV antibodies and HCV-RNA positivity among children attending University of Assiut Hospital, and to assess some of the risk factors for HCV infection. 
Methods

Sample
Laboratory methods
Blood samples were centrifuged and separated sera samples were kept at -70 °C prior to testing. All sera samples of the studied cases (n = 465) were tested by NeoDIN anti-HCV EIA 3rd generation, a qualitative assay for detection of HCV in human serum or plasma, according to the manufacturers' instructions and following standard infection control precautions to avoid self-infection.
All sera samples of the ELISA positive cases (n = 121) were tested for HCV-RNA by a PCR kit (Abgene House, UK), according to the manufacturer's instructions and following standard infection control precautions to avoid self-infection.
Liver function tests, including total and direct bilirubin, alanine aminotransferase (ALT), aspartate aminotransferase (AST) and alkaline phosphatase (ALP), were done for all 465 cases. ALT was selected to indicate the degree to which liver injury had occurred; it was considered abnormal if the level was > 2 times greater than the upper limit of the normal level, i.e. > 90 U/L, where the normal range is 5-45 U/L [7, 8] .
Data and specimen collection procedures were approved by the ethical committee for biochemical human studies at the university.
Analysis
The collected data were coded and analysed using SPSS, version 10. Simple statistics such as frequency, arithmetic mean and standard deviation (SD) were used. From 2 × 2 tables, odds ratios (OR) and 95% confidence intervals (CI) were calculated; P-value was determined using the chi-squared test. Table 1 shows selected demographic data of the study children. Among the 465 tested children, 121 tested positive for anti-HCV by ELISA (26.0%). The frequency of anti-HCV positivity by ELISA in cases of acute hepatitis was 8.7%, similar to the rate among the nonhepatitis, non-multitransfused children (8.0%) ( Table 2 ). The frequency of anti-HCV positivity in the multitransfused group was 58.2%.
Results
For patients with acute hepatitis, the rate of ELISA positivity was higher among rural then urban residents [12/125 cases (9.6%) versus 1/25 cases (4.0%)], and the same was true for the non-hepatiti,s non-multitransfused group [11/117 cases (9.4%) versus 1/33 (3.0%]. In the multi-transfused patients, the rates were similar in rural and urban areas [89/153 (58.1%) versus 7/12 (58.3%)].
The frequency of HCV-RNA positivity by PCR among the cases testing positive by ELISA (n = 121) was 72.2% overall, 100% in the hepatitis group, 70.8% in the multitransfused group and 58.3% in the non-hepatitis nonmultitransfused group (Table 2) . Table 3 shows some of the risk factors for anti-HCV positivity by ELISA testing. Significant risk factors were a positive history of blood transfusion (OR = 16.62; 95% CI: 9.32-29.91), frequent injections (OR = 3.05; 95% CI: 1.82-5.1), prior hospitalization (OR = 15.19; 95% CI: 8.31-31.03) and prior surgical procedure (OR = 3.48; 95% CI: 1.74-5.23). The frequency of anti-HCV positivity among males and females with a positive history of circumcision showed no significant difference from those with a negative history. Similarly, the frequency of anti-HCV positivity among females with a positive history of ear-piercing showed no significant difference from those with a negative history. The risk effect of some factors could not be analysed, either because the exposure was universal among the studied cases, such as hair-cutting by community barbers and insect bites, or because the exposure was nil, such as cauterization, tattooing and sharing toothbrushes.
Discussion
In non-hepatitis non-multitransfused children attending the Department of Paediatrics at the University of Assuit Hospital, the frequency of anti-HCV positivity by ELISA was 8.0%. The frequency in a previous study at this The presence of HCV-RNA in serum is a reliable indicator of infectivity and ongoing viral reproduction, and close follow-up of the infected cases is mandatory [23] . Presence of anti-HCV positivity in the absence of HCV-RNA positivity can be attributed to either a esolved HCV infection while the patient remains anti-HCV positive or a falsepositive ELISA test [19, 22] . If therapy is initiated for HCV infection solely on the basis of ELISA results, there will be a considerable risk of treating children who do not have HCV activation.
In the present study, those with a history of blood/plasma transfusion were 16 times more likely to have HCV than those who had not received a transfusion. In Egypt, blood transfusion remains an important past, and a potential current, risk factor for HCV transmission. Factors responsible for this situation include: the high anti-HCV hospital among control children admitted to hospital was 5.6% [9] , while in a community-based study in a village in Assiut governorate, the frequency was 1.9% for children aged < 9 years. This difference may be attributed not only to the difference in the study design but also to the age of the study population [3] . The lower frequency in the communitybased study than the 2 hospital-based studies in the same governorate may be attributed to differences in the study population as the hospital-based study included children who were seeking hospital care. Worldwide studies of the general paediatric population without identifiable risk factors reported much lower seroprevalence rates: 0 % in Japan [10] and 0.4% in Italy [11] . Socioeconomic differences are likely to explain much of the geographic variability in the prevalence of anti-HCV positivity.
The frequency of anti-HCV positivity by ELISA in the group with acute hepatitis was 8.7%. This was very similar to that in the non-hepatitis non-multitransfused group (8.0%), reflecting the endemicity of HCV infection among children in this locality. El-Zimaity et al. at Abbassia Fever Hospital in Cairo could not detect anti-HCV among acute hepatitis cases using 1st-generation ELISA testing; however, they assigned 19.5% of their cases as non-A-non-B hepatitis (hepatitis C, D, E, F, G and TT viruses) [12] . Low rates of positivity of anti-HCV by ELISA among acute hepatitis cases were reported from Morocco [13] . This difference may be explained by the lower rate of anti-HCV antibodies in the general population in Morocco (1.1%) [14] .
In the present study the frequency of anti-HCV positivity among the multitransfused group was 58.2%. Al-Kubaisy et al. detected HCV-specific antibodies in 67.3% of serum samples using 3rd-generation EIA and confirmatory immunoblot assays in Iraq [15] . In a 1993 study in the same hospital in Assiut the rate was reported as 27.6% [16] . In the present study, those who had a history of frequent injections were 3 times more likely to have HCV than those who had no history of prior frequent injections. HCV infection might occur through cross-transmission from unsafe and unnecessary frequent injections that are routine in most health care services and outpatient visits. The mechanism of transmitting HCV through repeated use of the same needles is similar to sharing of needles by intravenous drug users, where the probability of HIV infection has a clear correlation with the period and frequency of injection [26] . In Egypt there is a high frequency of therapeutic injections among the general population. Many injections are prescribed and administered by untrained medical providers such as pharmacists, barbers, tamargi (assistants to private medical doctors), housekeepers, relatives and friends. Reuse of syringes may occur, which is likely to contribute to bloodborne pathogen transmission. Health care workers underestimate patient-to-patient HCV infection; some may think that injection is safe when only the needle is changed between each patient, whereas a reused syringe may contain enough blood to cause HCV infection.
We found those who had a history of prior hospitalization were 15 times more likely to have HCV than those who had not been hospitalized before. One way of contracting HCV may be transmission from infected medical personnel to susceptible patients during medical care. Patient-to-patient transmission has also been reported in a haematology ward [27] , during colonoscopy in a gastrointestinal disease unit [28] and in a haemodialysis unit [29] . Nosocomial transmission of HCV through the use of multidose vials between several patients was reported by Widell et al. [30] . Multidose vials of local anaesthetics, saline, heparin and other solutions are used in different hospitals to reduce costs, and transmission of HCV may occur through contamination of the vials, or through forgetting to change the syringe between patients.
In the present study, those who had undergone a surgical procedure were more than 3 times more likely to have HCV than those who had not had prior surgery. Surgery can lead to HCV exposure through intravenous treatments, repeated blood drawing for testing and transfusion of blood products. The remote possibility of the use of unsterilized or inadequately sterilized contaminated instruments may add to the problem.
Conclusions
The frequency of HCV infection among children attending the University of Assiut Hospital was high, particularly among those exposed to multiple blood/plasma transfusions. History of blood transfusion, frequent injections, hospitalization or surgical procedures were important risk factors for HCV infection in Egypt. Avoidance of unnecessary blood transfusion and injections, and implementation of strict infection control measures are highly recommended to reduce the frequency of HCV infection.
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